Richard J. Moran

Who is Richard J. Moran?

Mr. Moran brings extensive and diversified finance experience from a

long career with Johnson and Johnson (JNJ) and several of its operating

companies. He served as Chief Financial Officer, Vice President

Finance, and member of the U.S.A. Board of Ortho Biotech from 1995

until 2002, and from 2000 to 2002 he assumed finance responsibility for

the Ortho Biotech Worldwide Board. In that role, he was responsible for

planning, preparation, management, compliance and controls of the

accounting and financial activities of this $4.4 billion global

business unit. From 2002 until his retirement in 2004, he served as

Director Special Projects at JNJ’s Corporate Headquarters, where he was

charged with strategic development and implementation of Sarbanes-Oxley

Section #404 compliance requirements at more than 350 worldwide

locations with $45 billion in sales. Mr. Moran previously served as

Finance Group Controller for JNJ’s International Cilag, Ortho, McNeil

Pharmaceuticals (ICOM) Group from 1989 to 1994 during the launch of

Eprex® in 50 countries and Procrit® in the U.S., and he served as a

Board member for both Cilag Europe and the ICOM Group. From 1983 to

1988, Mr. Moran was a Director of JNJ’s Corporate Internal Audit

Department. Prior to his service at JNJ, Mr. Moran was a Staff Auditor

for Arthur Andersen Co. Mr. Moran is a member of the New Jersey

Society of Certified Public Accountants, the American Institute of

Certified Public Accountants, and has served as Chairman of the Board

and Treasurer of the American Red Cross of Somerset County, NJ